Otc - Active Ingredient
Active ingredient:
- Salicylic Acid 17%
Totclear Wart And Spot Eraser Solution
FDA Label NDC 87725-002
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Good Bridge Llc for the product Totclear Wart And Spot Eraser (NDC 87725-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - when using, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Purpose
- Wart Remover
Indications & Usage
Uses:
- For the removal of common warts.
Warnings
For external use only
Otc - Do Not Use
- Do not use on broken skin.
- Avoid contact with eyes and mouth.
Otc - When Using
For external use only.
Otc - Stop Use
Stop use immediately if:
- Redness appears.
- Itching appears.
- Stinging irritation appears.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
Dosage & Administration
Directions:
- Keep skin clean and dry.
- Use the rollerball applicator to apply the serum evenly to the affected area and massage with your fingertips to promote absorption.
Inactive Ingredient
Inactive Ingredients:
- Aqua (Aqua)
- Glycerin (Glycerin)
- Allantoin (Allantoin)
- Propylene Glycol (Propylene Glycol)
- Carbomer (Carbomer)
- Melaleuca Alternifolia Leaf Oil (Tea Tree Oil)
- Triethanolamine (Trolamine)
- Euphorbia Esula Extract (Euphorbia Esula Whole)
- Phenoxyethanol (Phenoxyethanol)
- Ethylhexylglycerin (Ethylhexylglycerin)
Otc - Questions
Questions or comments?
Package Label.Principal Display Panel
Package Of Totclear Wart Spot Eraser 17% Salicylic Acid (Wart Spot)
* Please review the disclaimer below.
